PATENT CLAIM ANALYSIS

Application Number: 15763248
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "303000"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , and R 5  are as defined in the description. Medicinal products containing the same which are useful in treating cancer, neurodegenerative disorders and metabolic disorders.

Claim (Index 44):
The compound according to  claim 43 , wherein R 2  represents a \u2014(C 1 -C 6 )alkylene-O-pyridinyl group, wherein the pyridinyl group so defined may be optionally substituted by from 1 to 4 groups selected from linear or branched (C 1 -C 6 )alkyl, linear or branched (C 2 -C 6 )alkenyl, linear or branched (C 2 -C 6 )alkynyl, linear or branched (C 1 -C 6 )alkoxy, linear or branched (C 1 -C 6 )alkyl-S\u2014, hydroxy, oxo (or N-oxide where appropriate), nitro, cyano, \u2014C(O)\u2014OR\u2032, \u2014C(O)\u2014R\u2032, \u2014O\u2014C(O)\u2014R\u2032, \u2014C(O)\u2014NR\u2032R\u2033, \u2014NR\u2032\u2014C(O)\u2014R\u2033, \u2014NR\u2032R\u2033, linear or branched (C 1 -C 6 )polyhaloalkyl, difluoromethoxy, trifluoromethoxy, or halogen, wherein R\u2032 and R\u2033 independently of one another represent a hydrogen atom or a substituted linear or branched (C 1 -C 6 )alkyl group.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 90.0
- Lexical Diversity: 1.41176
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13266976', '14389336', '10524204', '11939735', '12089050']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7880709643419443
- 35 USC 102 Novelty (BERT): 0.5436371014448885
- Combined Prediction Score: 0.7636275780522388
- Mean Citation Score: 355.59789000000006
- Max Citation Score: 376.5085
- Similarity Product: 283.3411597180367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test